Article By:
Benzinga
Saturday, July 10, 2021 3:54 PM EDT
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the coming months.
